Ulla Hedner - Publications, H-index & Citations

Ulla Hedner

Novo Nordisk

62H指数

417论文数

1.2W被引数

收录论文 39

发表时间

Factor VIIa binding to endothelial cell protein C receptor: Differences between mouse and human systems 因子VIIa与内皮细胞蛋白C受体的结合: 小鼠和人类系统之间的差异

THROMBOSIS AND HAEMOSTASIS

IF4.3

2017-11-25

OAAI

Sen, Prosenjit; Clark, Curtis A.; Gopalakrishnan, Ramakrishnan; Hedner, Ulla; Esmon, Charles T.; Pendurthi, Usha R.; Rao, L. Vijaya Mohan

Fibrin gel structure obtained with a FVIIa analogue with enhanced FX-activating potential in haemophilia

THROMBOSIS AND HAEMOSTASIS

IF4.3

2017-11-24

PREAI

He, Shu; Ezban, Mirella; Bark, Niklas; Persson, Egon; Hedner, Ulla

Joint disease, the hallmark of haemophilia: What issues and challenges remain despite the development of effective therapies?

THROMBOSIS RESEARCH

IF3.4

2014-06-01

PREAI

Lambert, Thierry; Auerswald, Guenter; Benson, Gary; Hedner, Ulla; Jimenez-Yuste, Victor; Ljung, Rolf; Morfini, Massimo; Remor, Eduardo; Santagostino, Elena; Salek, Silva Zupancic

Progressive improvement in wound healing with increased therapy in haemophilia B mice

HAEMOPHILIA

IF3

2013-07-23

PREAI

Monroe, D. M.; Hoffman, M.; Roberts, H. R.; Hedner, U.

SWEDISH ADAPTATION OF CZECH PHARMACOECONOMIC COMPARISON OF TREATMENTS IN HAEMOPHILIA PATIENTS WITH INHIBITORS

VALUE IN HEALTH

IF6

2012-11-01

PREAI

Ericsson, A.; Mesterton, J.; Hedner, U.

Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa 内皮细胞蛋白C受体介导的因子VIIa的重新分布和组织水平的积累

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

IF5

2012-11-01

OAAI

Clark, C. A.; Vatsyayan, R.; Hedner, U.; Esmon, C. T.; Pendurthi, U. R.; Rao, L. V. M.

Analyses of recombinant activated factor VII treatments from clinical practice for rapid bleeding and acute pain control in haemophilia patients with inhibitors

HAEMOPHILIA

IF3

2012-08-29

PREAI

Salaj, P.; Ovesna, P.; Penka, M.; Hedner, U.

Influence of endothelial cell protein C receptor on plasma clearance of factor VIIa

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

IF5

2012-05-01

OAAI

Gopalakrishnan, R.; Pendurthi, U. R.; Hedner, U.; Agerso, H.; Esmon, C. T.; Rao, L. V. M.

Recombinant factor VIIa analog NN1731 (V158D/E296V/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma

THROMBOSIS RESEARCH

IF3.4

2011-12-01

OAAI

Gray, Laura D.; Hussey, Michael A.; Larson, Brittany M.; Machlus, Kellie R.; Campbell, Robert A.; Koch, Gary; Ezban, Mirella; Hedner, Ulla; Wolberg, Alisa S.

Joint protection in haemophilia

HAEMOPHILIA

IF3

2011-08-08

112

PREAI

Rodriguez-Merchan, E. C.; Jimenez-Yuste, V.; Aznar, J. A.; Hedner, U.; Knobe, K.; Lee, C. A.; Ljung, R.; Querol, F.; Santagostino, E.; Valentino, L. A.; Caffarini, A.

Monitoring rFVIIa 90 μg kg-1 dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6 h

HAEMOPHILIA

IF3

2011-03-01

PREAI

Brophy, D. F.; Martin, E. J.; Barrett, J. Christian; Nolte, M. E.; Kuhn, J. G.; Gerk, P. M.; Carr, M. E.; Pelzer, H.; Agerso, H.; Ezban, M.; Hedner, U.

Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following intravenous administration in hemophilia patients

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

IF5

2011-02-01

OAAI

Agerso, H.; Brophy, D. F.; Pelzer, H.; Martin, E. J.; Carr, M.; Hedner, U.; Ezban, M.

rFVIIa transported from the blood stream into tissues is functionally active

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

IF5

2010-10-01

OAAI

Gopalakrishnan, R.; Hedner, U.; Clark, C.; Pendurthi, U. R.; Rao, L. V. M.

Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa)

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

IF5

2010-02-01

OAAI

Gopalakrishnan, R.; Hedner, U.; Ghosh, S.; Nayak, R. C.; Allen, T. C.; Pendurthi, U. R.; Rao, L. V. M.

Thrombin generation and platelet activation induced by rFVIIa (NovoSeven®) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditions

HAEMOPHILIA

IF3

2009-10-26

PREAI

Aljamali, M. N.; Kjalke, M.; Hedner, U.; Ezban, M.; Tranholm, M.

Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic

HAEMOPHILIA

IF3

2009-04-21

PREAI

Salaj, P.; Brabec, P.; Penka, M.; Pohlreichova, V.; Smejkal, P.; Cetkovsky, P.; Dusek, L.; Hedner, U.

Prevention of haemophilic arthropathy during childhood. May common orthopaedic management be extrapolated from patients without inhibitors to patients with inhibitors?

HAEMOPHILIA

IF3

2008-09-29

PREAI

Rodriguez-Merchan, E. C.; Hedner, U.; Heijnen, L.; Jimenez-Yuste, V.; Lee, C. A.; Morfini, M.; Querol, F.; Roosendaal, G.; Santagostino, E.; Solimeno, L. P.

Downregulation of tissue factor (TF) by RNA interference induces apoptosis and impairs cell survival of primary endothelium and tumor cells

CELL AND TISSUE RESEARCH

IF2.9

2008-07-30

PREAI

Osterholm, Cecilia; Li, Shushun; Ekberg, Henrik; Hedner, Ulla; Holgersson, Jan

Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

IF5

2008-05-01

PREAI

Lauritzen, B.; Hedner, U.; Johansen, P. B.; Tranholm, M.; Ezban, M.